# 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

> **NCT00616733** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 25 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** CS-0777 tablets
- **DRUG:** CS-0777 tablets
- **DRUG:** CS-0777 tablets

## Key facts

- **NCT ID:** NCT00616733
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2011-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00616733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00616733, "12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00616733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*